Structural resolution of protein interactions enables mechanistic and functional studies as well as interpretation of disease variants. However, structural data is still missing for most protein interactions because we lack computational and experimental tools at scale. This is particularly true for interactions mediated by short linear motifs occurring in disordered regions of proteins. We find that AlphaFold-Multimer predicts with high sensitivity but limited specificity structures of domain-motif interactions when using small protein fragments as input. Sensitivity decreased substantially when using long protein fragments or full length proteins. We delineated a protein fragmentation strategy particularly suited for the prediction of domain-motif interfaces and applied it to interactions between human proteins associated with neurodevelopmental disorders. This enabled the prediction of highly confident and likely disease-related novel interfaces, which we further experimentally corroborated for FBXO23-STX1B, STX1B-VAMP2, ESRRG-PSMC5, PEX3-PEX19, PEX3-PEX16, and SNRPB-GIGYF1 providing novel molecular insights for diverse biological processes. Our work highlights exciting perspectives, but also reveals clear limitations and the need for future developments to maximize the power of Alphafold-Multimer for interface predictions. Synopsis: Based on thorough benchmarking of AlphaFold-Multimer a strategy for structure prediction was developed and applied to 62 protein interactions linked to neurological disease. Six novel protein interfaces were further experimentally corroborated. AlphaFold-Multimer (AF) largely fails to predict structures of interacting proteins involving short linear motifs when using full length sequences. A prediction strategy was developed based on protein fragmentation, which boosts AF sensitivity at costs of specificity. Application of this strategy to 62 protein interactions linked to neurological disease resulted in 18 correct or likely correct structural models. Six novel protein interfaces were further supported by experiments. Based on thorough benchmarking of AlphaFold-Multimer a strategy for structure prediction was developed and applied to 62 protein interactions linked to neurological disease. Six novel protein interfaces were further experimentally corroborated. [ABSTRACT FROM AUTHOR]